Show simple item record

dc.contributor.authorHunt, William
dc.contributor.authorFrow, Helen
dc.date.accessioned2019-03-19T16:33:25Z
dc.date.available2019-03-19T16:33:25Z
dc.date.issued2019-02
dc.identifier.citationTso S [et al]. Systemic agents for psoriasis and their relevance to primary care. Br J Gen Pract. 2019 Feb;69(679):96-97en_US
dc.identifier.pmid30705021
dc.identifier.doi10.3399/bjgp19X701225
dc.identifier.urihttps://rde.dspace-express.com/handle/123456789/620973
dc.description.abstractPsoriasis is a common chronic autoimmune inflammatory disease. There is an increasing range of systemic agents prescribed by specialists in the management of psoriasis. Thus, it is important for clinicians to become familiar with these medicines. This article aims to answer questions commonly asked about these medicines in relation to their side effects and their impact on vaccinations, preconception planning, breastfeeding, infection management, and major elective surgery.en_US
dc.language.isoenen_US
dc.publisherRoyal College of General Practitionersen_US
dc.relation.urlhttp://bjgp.org/cgi/pmidlookup?view=long&pmid=30705021en_US
dc.subjectWessex Classification Subject Headings::Dermatologyen_US
dc.titleSystemic agents for psoriasis and their relevance to primary careen_US
dc.typeJournal Articleen_US
dc.identifier.journalBritish Journal of General Praticeen_US
dc.identifier.pmcidPMC6355284
dc.type.versionPublisheden_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record